Monoclonal Antibodies and Immuno-Oncology in Cancer Therapeutics...

added blog Other

2026-09-07 16:31:58 -

Monoclonal Antibodies and Immuno-Oncology in Cancer Therapeutics Biotherapeutic Market

Monoclonal antibodies (mAbs) represent the single largest therapeutic segment within modern biological oncology due to their high specificity, versatile mechanisms of action, and proven clinical outcomes. Whether functioning as direct cell-death triggers, anti-angiogenic agents that starve tumors of blood supply, or delivery vehicles for cytotoxic payloads in Antibody-Drug Conjugates (ADCs),...

0 Comments 0 Shares 9 Views 0 Reviews